WO2003077883A3 - Composition and utilization thereof for forming a protective film on nasal mucous membranes - Google Patents

Composition and utilization thereof for forming a protective film on nasal mucous membranes Download PDF

Info

Publication number
WO2003077883A3
WO2003077883A3 PCT/CH2003/000173 CH0300173W WO03077883A3 WO 2003077883 A3 WO2003077883 A3 WO 2003077883A3 CH 0300173 W CH0300173 W CH 0300173W WO 03077883 A3 WO03077883 A3 WO 03077883A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
mucous membranes
forming
nasal mucous
water
Prior art date
Application number
PCT/CH2003/000173
Other languages
German (de)
French (fr)
Other versions
WO2003077883A2 (en
Inventor
Toni Pfluger
Original Assignee
Kuyus Stiftung
Toni Pfluger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuyus Stiftung, Toni Pfluger filed Critical Kuyus Stiftung
Priority to AU2003208245A priority Critical patent/AU2003208245A1/en
Publication of WO2003077883A2 publication Critical patent/WO2003077883A2/en
Publication of WO2003077883A3 publication Critical patent/WO2003077883A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Abstract

The invention relates to a composition for preventing reactions and/or diseases provoked, inter alia, by pathogens, allergens, pollen, virus and dust entering through the nasal mucous membranes. The composition contains organic compounds received in water or water/solvent for forming a sealing of the nasal mucous membranes with an elastic protective film. The compounds comprise at least one natural or synthetic organic polymer acting as a film former, at least one silicon compound and water in which the film former and the silicon compound are dissolved or emulsified. The activity of the composition can be further enhanced by adding a gel-forming substance. The composition does not contain any reactive components which react with air-borne substances but rather owes its effect to the physical barrier function.
PCT/CH2003/000173 2002-03-15 2003-03-17 Composition and utilization thereof for forming a protective film on nasal mucous membranes WO2003077883A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003208245A AU2003208245A1 (en) 2002-03-15 2003-03-17 Composition and utilization thereof for forming a protective film on nasal mucous membranes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4502002 2002-03-15
CH450/02 2002-03-15

Publications (2)

Publication Number Publication Date
WO2003077883A2 WO2003077883A2 (en) 2003-09-25
WO2003077883A3 true WO2003077883A3 (en) 2003-11-13

Family

ID=27810648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2003/000173 WO2003077883A2 (en) 2002-03-15 2003-03-17 Composition and utilization thereof for forming a protective film on nasal mucous membranes

Country Status (2)

Country Link
AU (1) AU2003208245A1 (en)
WO (1) WO2003077883A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343464B2 (en) * 2010-04-30 2013-01-01 Burns Phillip E Composition and method for treating eustachian tube dysfunction
BE1018740A3 (en) * 2010-08-10 2011-07-05 Oystershell Nv COMPOSITION FOR THE TREATMENT OF HUMID EPITHELIAL SURFACES.
DE102014009164A1 (en) * 2014-06-03 2015-12-03 Herbalist & Doc Gesundheitsgesellschaft Mbh Silicone oil containing nasal formulations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1108837A (en) * 1965-11-30 1968-04-03 Astra Pharma Prod Improvements in material for causing local anaesthesia
JPH0320217A (en) * 1989-06-16 1991-01-29 Eisai Co Ltd Nasal inhalant cataplasm
EP0474098A1 (en) * 1990-08-30 1992-03-11 Senju Pharmaceutical Co., Ltd. Controlled drug release composition
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
FR2814075A1 (en) * 2000-09-18 2002-03-22 Phyt Immun Gmbh Nasal ointment for prophylaxis of inhalation-allergic reactions, especially hay fever, comprising mixture of saturated hydrocarbons and tannin(s)
WO2002076432A2 (en) * 2001-03-26 2002-10-03 Novartis Ag Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1108837A (en) * 1965-11-30 1968-04-03 Astra Pharma Prod Improvements in material for causing local anaesthesia
JPH0320217A (en) * 1989-06-16 1991-01-29 Eisai Co Ltd Nasal inhalant cataplasm
EP0474098A1 (en) * 1990-08-30 1992-03-11 Senju Pharmaceutical Co., Ltd. Controlled drug release composition
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
FR2814075A1 (en) * 2000-09-18 2002-03-22 Phyt Immun Gmbh Nasal ointment for prophylaxis of inhalation-allergic reactions, especially hay fever, comprising mixture of saturated hydrocarbons and tannin(s)
WO2002076432A2 (en) * 2001-03-26 2002-10-03 Novartis Ag Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 015, no. 137 (C - 0821) 5 April 1991 (1991-04-05) *

Also Published As

Publication number Publication date
AU2003208245A1 (en) 2003-09-29
AU2003208245A8 (en) 2003-09-29
WO2003077883A2 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
EP1785167A3 (en) Adsorbing filter material with a biological and chemical protection function and its use
MX2009005495A (en) Coating agents having high scratch resistance and weathering stability.
WO2003032953A1 (en) Granules containing acid-unstable chemical in large amount
CL2007002594A1 (en) COMPOUNDS DERIVED FROM PIRIDIN-3-IL, IMMUNOMODULATING AGENTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN ACTIVATED IMMUNOLOGICAL SYSTEM. .
WO2005055973A3 (en) Endoparasiticidal agents for topical application
WO2009108695A3 (en) Methods for prevention and treatment of acute renal injury
BRPI0716725A2 (en) pesticide composition were a gel or solid, use of a compound, method for combating arthropod pests, device, and use of the pesticide composition
EP1362788A3 (en) Devices, systems and methods for the containing and use of liquid solutions
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
WO2003090470A3 (en) Methods and systems for preventing start code emulation at non-byte aligned and/or bit-shifted locations
WO2004089396A3 (en) Anti-fungal peptidomimetics
ATE472346T1 (en) VENTILATION SYSTEM FOR NBC PROTECTION
WO2005107773A3 (en) Solid dosage form of wetted heparin
WO2003077883A3 (en) Composition and utilization thereof for forming a protective film on nasal mucous membranes
MX2007007650A (en) Method for laminating using special cross-linked carbodiimide groups.
BRPI0417763A (en) breathable elastic laminates and manufacturing methods thereof
WO2007076322A3 (en) Compositions and methods for attenuating mitochondria-mediated cell injury
WO2009023317A3 (en) Personal debris shield and system
ATE392900T1 (en) USE OF INDIGESTIBLE POLYMERIC FOAM TO ENAPSULE INGESTED SUBSTANCES, WHEREAS PREVENTING THEIR ABSORPTION BY THE BODY
EP1627873A4 (en) Benzofuran compound and medicinal composition containing the same
BRPI0407639A (en) method for preparing water dispersible granules
EP2218976A3 (en) Air curtain with an auxiliary stream
WO2004014336A3 (en) Opioid-receptor antagonists in transdermal systems having buprenorphine
WO2004078125A3 (en) Aerosol antiperspirant with polyamide
WO2002040817A3 (en) Flood protection system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP